We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Eli Lilly and Co | NYSE:LLY | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-15.91 | -2.10% | 740.00 | 745.00 | 730.34 | 743.10 | 4,593,881 | 01:00:00 |
Indiana
(State or Other Jurisdiction
of Incorporation)
Lilly Corporate Center
Indianapolis, Indiana
(Address of Principal
Executive Offices)
|
001-06351
(Commission
File Number)
|
35-0470950
(I.R.S. Employer
Identification No.)
46285
(Zip Code)
|
No Change
|
Nominee
|
For
|
Against
|
Abstain
|
Broker Nonvote
|
Ralph Alvarez
|
759,493,583
|
27,201,067
|
1,696,439
|
112,139,655
|
R. David Hoover
|
780,873,127
|
5,870,808
|
1,647,154
|
112,139,655
|
Juan R. Luciano
|
783,741,391
|
3,285,103
|
1,364,595
|
112,139,655
|
Franklyn G. Prendergast, M.D., Ph.D.
|
778,390,104
|
8,168,776
|
1,832,209
|
112,139,655
|
Kathi P. Seifert
|
771,733,157
|
14,097,112
|
2,560,820
|
112,139,655
|
b)
|
By the following vote, the shareholders approved an advisory vote on compensation paid to named executive officers:
|
c)
|
The appointment of Ernst & Young as our principal independent auditor was ratified by the following shareholder vote:
|
For:
|
879,711,314
|
Against:
|
19,638,570
|
Abstain:
|
1,180,860
|
d)
|
By the following vote, a shareholder proposal seeking a report regarding how we select the countries in which we operate or invest was not approved:
|
For:
|
10,637,179
|
Against:
|
737,089,093
|
Abstain:
|
40,664,817
|
Broker Nonvote:
|
112,139,655
|
1 Year Eli Lilly Chart |
1 Month Eli Lilly Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions